Pricing Log in Create free account

Decoy Therapeutics Inc (DCOY) vs Revelation Biosciences, Inc. (REVB)

Decoy Therapeutics Inc and Revelation Biosciences, Inc. are both Biotechnology companies. Decoy Therapeutics Inc and Revelation Biosciences, Inc. are of similar size ($3.0M and $2.9M). Revelation Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Decoy Therapeutics Inc trades at 0.0×. Revelation Biosciences, Inc. has the higher net margin (0.00% vs −698.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Revelation Biosciences, Inc. leads on 8 and Decoy Therapeutics Inc on 5.

Valuation

Metric DCOY REVB Biotechnology median
P/E 0.01 n/m 8.50
P/S 0.30 n/m 9.71
P/B 0.14 0.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.49 0.86 0.64
EV/Sales (3.48) n/m 9.21
Earnings yield 15,691.12% (2,564.58%) (33.15%)
Free cash flow yield (1,677.54%) (513.59%) (25.50%)

Profitability

Metric DCOY REVB Biotechnology median
Gross margin 10.57% 0.00% 65.16%
Operating margin (706.88%) 0.00% 0.00%
Net margin (698.79%) 0.00% 0.00%
Free cash flow margin (432.43%) 0.00% 0.00%
Return on equity (827.77%) (276.43%) (56.36%)
Return on assets (278.04%) (214.63%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DCOY REVB Biotechnology median
Revenue growth (TTM) (60.49%) — 6.02%
EPS growth (last fiscal year) (85.66%) 97.72% 30.26%
Revenue growth, 5-year CAGR 12.73% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DCOY REVB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.83 6.21 4.72
Net debt to EBITDA 0.85 1.18 0.96

Dividend

Metric DCOY REVB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DCOY REVB Biotechnology median
Market cap 2.93m 3.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack